Aquí están nuestras presentaciones de los diferentes artículos.
Faltan algunos, los no marcados en negrita. O la gente no los ha enviado o yo los he perdido.
Enviádmelos para colgarlos a vipegar@alumni.uv.es
(si falla alguno o tenéis algún problema enviadme un e-mail)
Actualizado
10/6/05
-añadiado 1_19 y 2_21
9/6/05
-añadido 2_22
30/5/05
-añadido 2_19
25/5/05
-añadido 2_17
24/5/05
-añadido 2_1
23/5/05 19:00
-Corregido link al fichero tanda1_3
23/5/05 13:45
-Añadidas presentaciones 1_16 y 2_2
Primera tanda de Artículos |
||||
|
Quién |
Cuándo |
Qué |
documento |
Tanda1_1 |
Carlos Romá |
11/2/05 |
Zeitlin P. Can curcumin cure cystic fibrosis? N Engl J Med. 2004 Aug 5;351(6):606-8. |
curcumin.pdf |
Tanda1_2 |
Amparo García |
11/2/05 |
Rando TA. Artificial sweeteners--enhancing glycosylation to treat muscular dystrophies. N Engl J Med. 2004 Sep 16;351(12):1254-6. |
sweeteners.pdf |
Tanda1_3 |
Silvia Llopis |
11/2/05 |
Lane D.Curing cancer with p53. N Engl J Med. 2004 Jun 24;350(26):2711-2 |
p53.pdf |
Tanda1_4 |
Juan José Muñoz |
11/2/05 |
Doms RW. Viral entry denied. N Engl J Med. 2004 Aug 19;351(8):743-4. |
viralentry.pdf |
Tanda1_5 |
Patricia Hernández |
18/2/05 |
Johnston RE. A candidate vaccine for severe acute respiratory syndrome (SARS). N Engl J Med. 2004 Aug 19;351(8):827-8. |
SARS.pdf |
Tanda1_6 |
Lorena Mengual |
18/2/05 |
Pellegrini G. Changing the cell source in cell therapy? N Engl J Med. 2004 Sep 16;351(12):1170-2Nishida K, Yamato M, et al. Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium. N Engl J Med. 2004 Sep 16;351(12):1187-96 |
cellsource.pdfcornea.pdf |
Tanda1_7 |
Andrés P. Gagete |
18/2/05 |
Levine F, Mercola M. No pancreatic endocrine stem cells? N Engl J Med. 2004 Sep 2;351(10):1024-6 |
pancreaticstem.pdf |
Tanda1_8 |
Sonia Mayo |
18/2/05 |
Jaenisch R. Human cloning - the science and ethics of nuclear transplantation. N Engl J Med. 2004 Dec 30;351(27):2787-91. |
cloning.pdf |
Tanda1_9 |
Juan Bodí |
18-25/2/05 |
Cookson W, Moffatt M. Making sense of asthma genes. N Engl J Med. 2004 Oct 21;351(17):1794-6 |
asma.pdf |
Tanda1_10 |
Fabrice C Durupt |
18-25/2/05 |
Feany MB. New genetic insights into Parkinson's disease. N Engl J Med. 2004 Nov 4;351(19):1937-40Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N Engl J Med. 2004 Nov 4; 351(19):1972-7 |
parkinson.pdfglucocerebrosidasa.pdf |
Tanda1_11 |
Silvia Breña |
25/2/05 |
Caraco Y. Genes and the response to drugs. N Engl J Med. 2004 Dec 30;351(27):2867-9.Gasche Y, Daali Y, Fathi M, Chiappe A, Cottini S, Dayer P, Desmeules J. Codeine intoxication associated with ultrarapid CYP2D6 metabolism. N Engl J Med. 2004 Dec 30;351(27):2827-31. |
farmacogenetica.pdfcodeine.pdf |
Tanda1_12 |
Camila Ochoa |
25/2/05 |
Vernick KD, Waters AP. Genomics and malaria control.N Engl J Med. 2004 Oct 28;351(18):1901-4. |
malaria.pdf |
Tanda1_13 |
Vicente Pelechano |
25/2/05-4/3/05 |
Chamberlain JS. Cachexia in cancer--zeroing in on myosin. N Engl J Med. 2004 Nov 11;351(20):2124-5. |
caquexia.pdf |
Tanda1_14 |
Emilio J. Laserna |
25/2/05-4/3/05 |
Singh SK, Hawkins C, et al. Identification of human brain tumour initiating cells. Nature. 2004 Nov 18;432(7015):396-401. Clarke MF. Neurobiology: at the root of brain cancer. Nature. 2004 Nov 18;432(7015):281-2 |
braintumor.pdfbraincancer.pdf |
Tanda1_15 |
Sheila Ros |
4/3/05 |
Houghton J, Stoicov C, et al. Gastric cancer originating from bone marrow-derived cells.Science. 2004 Nov 26;306(5701):1568-71. Comentario: Science 2004 Nov 26;306(5701):1455-7 |
gastriccancer.pdfcomentarioscience.pdf |
Tanda1_16 |
Jesús Prieto |
4/3/05 |
Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science. 2004 Aug 27;305(5688):1292-5. |
cuervosinucleina.pdf |
Tanda1_17 |
Francisco J Jódar |
4/3/05-11/3/05 |
Cuervo AM. Autophagy: in sickness and in health. Trends Cell Biol. 2004 Feb;14(2):70-7 |
cuervoautofagia.pdf |
Tanda1_18 |
Jorge Jiménez |
4/3/05-11/3/05 |
Tansey WP. Death, destruction, and the proteasomeN Engl J Med. 2004 Jul 22;351(4):393-4 |
proteasoma.pdf |
Tanda1_19 |
Rafael Ruiz |
11/3/05 |
Omary MB, Coulombe PA, McLean WH.Intermediate filament proteins and their associated diseases. N Engl J Med. 2004 Nov 11;351(20):2087-100. |
filamentos.pdf |
Tanda1_20 |
Mª Ángeles Nohales |
11/3/05 |
Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, Morrow JD, Cawthon RM. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17312-5. |
telómerostress.pdf |
Tanda1_21 |
David Serquera |
11/3/05-15/3/05 |
Wickelgren I.A wily recruiter in the battle against toxic beta amyloid aggregation.Science. 2004 Oct 29;306(5697):791-2.Gestwicki JE, Crabtree GR, Graef IAHarnessing chaperones to generate small-molecule inhibitors of amyloid beta aggregation.Science. 2004 Oct 29;306(5697):865-9. |
Alzheimercomscience.pdfAlzheimerscience.pdef |
Tanda1_22 |
José Luis Llácer |
11/3/05-15/3/05 |
Hutter-Paier B, Huttunen HJ, Puglielli L, Eckman CB, Kim DY, Hofmeister A, Moir RD, Domnitz SB, Frosch MP, Windisch M, Kovacs DM.The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's diseaseNeuron. 2004 Oct 14;44(2):227-38. |
Alzheimerneuron.pdf |
Tanda1_23 |
Patricia Narbón |
11/3/05-15/3/05 |
Cummings JL. Drug therapy: Alzheimer's disease. N Engl J Med. 2004 Jul 1;351(1):56-67. |
Alzheimertherapy.pdf |
Segunda tanda de Artículos |
||||
|
Quién |
Cuándo |
Qué |
documento |
Tanda2_1 |
Carlos Romá |
15/4/05 |
Pandolfi PP. Breast cancer--loss of PTEN predicts resistance to treatment.N Engl J Med. 2004 Nov 25;351(22):2337-8. |
cancermama.pdf |
Tanda2_2 |
Jesús Prieto |
15/4/05 |
Benveniste M, Dingledine R. Limiting stroke-induced damage by targeting an acid channel. N Engl J Med. 2005 Jan 6;352(1):85-6 |
stroke.pdf |
Tanda2_3 |
Francisco J Jódar |
15/4/05 |
Velasco G, Galve-Roperh I, Sanchez C, Blazquez C, Guzman M. Hypothesis: cannabinoid therapy for the treatment of gliomas? Neuropharmacology. 2004 Sep;47(3):315-23. (largo) |
guzman.pdf |
Tanda2_4 |
Andrés P. Gagete |
15/4/05-22/4/05 |
Stevenson M. Therapeutic potential of RNA interference. N Engl J Med. 2004 Oct 21;351(17):1772-7. (largo) |
rnai.pdf |
Tanda2_5 |
Vicente Pelechano |
22/4/05 |
Sullenger BA. Riboswitches--to kill or save the messenger. N Engl J Med. 2004 Dec 23;351(26):2759-60. |
riboswitchesNEJM.pdf |
Tanda2_6 |
Juan Bodí |
22/4/05 |
Nimjee SM, Rusconi CP, Sullenger BA. Aptamers: an emerging class of therapeutics. Annu Rev Med. 2005;56:555-83. (largo) |
aptamers.pdf |
Tanda2_7 |
Emilio J. Laserna |
22/4/05 |
Peek RM Jr. Intoxicated cells and stomach ulcers. Nat Genet. 2003,33:328-30. Fujikawa A, Shirasaka D, Yamamoto S, Ota H, Yahiro K, Fukada M, Shintani T,Wada A, Aoyama N, Hirayama T, Fukamachi H, Noda M. Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori. Nat Genet. 2003 Mar;33(3):375-81. |
helipilrev.pdf helipil.pdf |
Tanda2_8 |
Silvia Breña |
29/4/05 |
Goldman JM, Melo JV. Chronic myeloid leukemia--advances in biology and new approaches to treatment. N Engl J Med. 2003 Oct 9;349(15):1451-64. |
leucemia.pdf |
Tanda2_9 |
Juan José Muñoz |
29/4/05 |
Downing JR. TGF-beta signaling, tumor suppression, and acute lymphoblastic leukemia. N Engl J Med. 2004 Aug 5;351(6):528-30.Wolfraim LA, Fernandez TM, Mamura M, Fuller WL, Kumar R, Cole DE, Byfield S, Felici A, Flanders KC, Walz TM, Roberts AB, Aplan PD, Balis FM, Letterio JJ. Loss of Smad3 in acute T-cell lymphoblastic leukemia. N Engl J Med. 2004 Aug 5;351(6):552-9. |
leucemiaedit.pdf leucemialinfo.pdf |
Tanda2_10 |
David Serquera |
29/4/05 |
Asante EA, Linehan JM, Desbruslais M, Joiner S, Gowland I, Wood AL, Welch J,Hill AF, Lloyd SE, Wadsworth JD, Collinge J. BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J. 2002 Dec 2;21(23):6358-66. (largo) |
prion.pdf |
Tanda2_11 |
Fabrice C Durupt |
6/5/05 |
Trejo JL, Carro E, Garcia-Galloway E, Torres-Aleman I. Role of insulin-like growth factor I signaling in neurodegenerative diseases. J Mol Med. 2004 Mar;82(3):156-62. (largo) |
torres.pdf |
Tanda2_12 |
Jorge Jiménez |
6/5/05 |
Weintraub SJ, Manson SR. Asparagine deamidation: a regulatory hourglass. Mech Ageing Dev. 2004 Apr;125(4):255-7. |
deamidacion.pdf |
Tanda2_13 |
Sheila Ros |
6/5/05 |
Lipton SA. Erythropoietin for neurologic protection and diabetic neuropathy. N Engl J Med. 2004 Jun 10;350(24):2516-7. |
eritropoyetina.pdf |
Tanda2_14 |
Patricia Hernández |
6/5/05-10/5/05 |
High K. Anemia and gene therapy--a matter of control. N Engl J Med. 2005 Mar 17;352(11):1146-7. |
eritroan.pdf |
Tanda2_15 |
Amparo García |
10/5/05 |
McNally EM. Powerful genes--myostatin regulation of human muscle mass. N Engl J Med. 2004 Jun 24;350(26):2642-4.Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, Braun T, Tobin JF, Lee SJ. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med. 2004 Jun 24;350(26):2682-8. |
miostatinrev.pdf miostatin.pdf |
Tanda2_16 |
Silvia Llopis |
10/5/05 |
Madara J. Building an intestine--architectural contributions of commensal bacteria. N Engl J Med. 2004 Oct 14;351(16):1685-6. |
intestino.pdf |
Tanda2_17 |
Camila Ochoa |
10/5/05-13/5/05 |
Agre P, Kozono D Aquaporin water channels: molecular mechanisms for human disease FEBS Lett. 2003, 555:72-78 |
aquaporins.pdf |
Tanda2_18
|
Sonia Mayo |
13/5/05 |
MacKinnon R Potassium Channels. FEBS Lett. 2003, 555:62-65 |
Kchannels.pdf |
Tanda2_19 |
José Luis Llácer |
13/5/05 |
Fernández C, Wüthrich K. NMR solution structure determination of membrane proteins reconstituted in detergent micelles. FEBS Lett. 2003, 555:144-150 |
NMR.pdf |
|
|
|
|
|
Tanda2_20 |
Lorena Mengual |
|
|
|
Tanda2_21 |
Rafael Ruiz |
|
|
|
Tanda2_22 |
Mª Ángeles Nohales |
|
|
|
Tanda2_23 |
Patricia Narbón |
|
|
|